151 related articles for article (PubMed ID: 19326049)
1. Screening of a PKC zeta-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis.
Wu J; Zhang B; Wu M; Li H; Niu R; Ying G; Zhang N
Invest New Drugs; 2010 Jun; 28(3):268-75. PubMed ID: 19326049
[TBL] [Abstract][Full Text] [Related]
2. A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice.
Wu J; Liu S; Fan Z; Zhang L; Tian Y; Yang R
Tumour Biol; 2016 Jun; 37(6):8391-401. PubMed ID: 26733166
[TBL] [Abstract][Full Text] [Related]
3. J-4: a novel and typical preclinical anticancer drug targeting protein kinase C ζ.
Li H; Wu J; Ying G; Chen L; Lai L; Liu Z; Zhang N; Guo H
Anticancer Drugs; 2012 Aug; 23(7):691-7. PubMed ID: 22430047
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C zeta is required for epidermal growth factor-induced chemotaxis of human breast cancer cells.
Sun R; Gao P; Chen L; Ma D; Wang J; Oppenheim JJ; Zhang N
Cancer Res; 2005 Feb; 65(4):1433-41. PubMed ID: 15735031
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of PKCzeta expression inhibits chemotaxis signal transduction in human lung cancer cells.
Liu Y; Wang B; Wang J; Wan W; Sun R; Zhao Y; Zhang N
Lung Cancer; 2009 Feb; 63(2):210-8. PubMed ID: 18701187
[TBL] [Abstract][Full Text] [Related]
6. Reduction of Akt2 expression inhibits chemotaxis signal transduction in human breast cancer cells.
Wang J; Wan W; Sun R; Liu Y; Sun X; Ma D; Zhang N
Cell Signal; 2008 Jun; 20(6):1025-34. PubMed ID: 18353613
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cells.
Liu Y; Wang J; Wu M; Wan W; Sun R; Yang D; Sun X; Ma D; Ying G; Zhang N
Mol Cancer Res; 2009 Jun; 7(6):944-54. PubMed ID: 19531564
[TBL] [Abstract][Full Text] [Related]
8. Pivotal Advance: PKCzeta is required for migration of macrophages.
Guo H; Ma Y; Zhang B; Sun B; Niu R; Ying G; Zhang N
J Leukoc Biol; 2009 Jun; 85(6):911-8. PubMed ID: 19201988
[TBL] [Abstract][Full Text] [Related]
9. The role of PKC in CXCL8 and CXCL10 directed prostate, breast and leukemic cancer cell migration.
Alassaf E; Mueller A
Eur J Pharmacol; 2020 Nov; 886():173453. PubMed ID: 32777211
[TBL] [Abstract][Full Text] [Related]
10. Effect of 4-methyl-3-nitrobenzoic acid on non‑small cell lung cancer cell migration.
Chen P; Zhang X; Guo H; Ma N; Li M; Liu Z; Zhang N; Hao X
Mol Med Rep; 2011; 4(5):947-53. PubMed ID: 21725598
[TBL] [Abstract][Full Text] [Related]
11. mTOR complex component Rictor interacts with PKCzeta and regulates cancer cell metastasis.
Zhang F; Zhang X; Li M; Chen P; Zhang B; Guo H; Cao W; Wei X; Cao X; Hao X; Zhang N
Cancer Res; 2010 Nov; 70(22):9360-70. PubMed ID: 20978191
[TBL] [Abstract][Full Text] [Related]
12. The involvement of lipid rafts in epidermal growth factor-induced chemotaxis of breast cancer cells.
Liu Y; Sun R; Wan W; Wang J; Oppenheim JJ; Chen L; Zhang N
Mol Membr Biol; 2007; 24(2):91-101. PubMed ID: 17453416
[TBL] [Abstract][Full Text] [Related]
13. PKCζ phosphorylates VASP to mediate chemotaxis in breast cancer cells.
Wang C; Zhao X; Zhao L; Wang Y; Jia Y; Zhang X; Ma W
Exp Cell Res; 2023 Dec; 433(2):113823. PubMed ID: 37890607
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
[TBL] [Abstract][Full Text] [Related]
15. Characterization of EGF-guided MDA-MB-231 cell chemotaxis in vitro using a physiological and highly sensitive assay system.
Biswenger V; Baumann N; Jürschick J; Häckl M; Battle C; Schwarz J; Horn E; Zantl R
PLoS One; 2018; 13(9):e0203040. PubMed ID: 30212492
[TBL] [Abstract][Full Text] [Related]
16. PLC and PI3K pathways are important in the inhibition of EGF-induced cell migration by gefitinib ('Iressa', ZD1839).
Shien T; Doihara H; Hara H; Takahashi H; Yoshitomi S; Taira N; Ishibe Y; Teramoto J; Aoe M; Shimizu N
Breast Cancer; 2004; 11(4):367-73. PubMed ID: 15604992
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor promotes MDA-MB-231 breast cancer cell migration through a phosphatidylinositol 3'-kinase and phospholipase C-dependent mechanism.
Price JT; Tiganis T; Agarwal A; Djakiew D; Thompson EW
Cancer Res; 1999 Nov; 59(21):5475-8. PubMed ID: 10554021
[TBL] [Abstract][Full Text] [Related]
18. A parallel-gradient microfluidic chamber for quantitative analysis of breast cancer cell chemotaxis.
Saadi W; Wang SJ; Lin F; Jeon NL
Biomed Microdevices; 2006 Jun; 8(2):109-18. PubMed ID: 16688570
[TBL] [Abstract][Full Text] [Related]
19. Quantitative study of the interactome of PKCζ involved in the EGF-induced tumor cell chemotaxis.
Chen R; Wang Y; Liu Y; Zhang Q; Zhang X; Zhang F; Shieh CH; Yang D; Zhang N
J Proteome Res; 2013 Mar; 12(3):1478-86. PubMed ID: 23402259
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of cPLA2γ expression inhibits EGF-induced chemotaxis of human breast cancer cells through Akt pathway.
Tian G; Wang X; Zhang F; Geng H; Hou W; Chen L; Guo H; Zhang N
Biochem Biophys Res Commun; 2011 Jun; 409(3):506-12. PubMed ID: 21600875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
